Valuation dashboard for Ekso Bionics Holdings, Inc. (EKSO) with P/E N/A, P/B 9.87, EV/EBITDA -2.91 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Technology companies.
Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton.
Analysis Summary
Ekso Bionics Holdings, Inc. reported revenue of $12.8M in the most recent fiscal year, growing at a 5-year CAGR of 7.6%.
Trailing-twelve-month margins: gross margin 52.9%, operating margin -134.1%, net margin -135.7%.
At the current price of $15.90, EKSO has negative trailing earnings (P/E not meaningful) and an ROE of -177.40%. Market capitalisation stands at $39M.
Balance sheet quality for EKSO: current ratio of 1.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 9.87 |
| EV / EBITDA | -2.91 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-86.93 |
| vs Current Price | -646.7% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| EKSO | Ekso Bionics Holdings, Inc. | $39M | 9.87 | -177.4% | |
| IBM | International Business Machines Corporation | $223.7B | 21.27 | 6.64 | 33.5% |
| 0Y0Y.L | Accenture plc | $122.2B | |||
| ACN | Accenture plc | $116.2B | 15.32 | 3.71 | 25.0% |
| INFY | Infosys Limited | $45.0B | 13.17 | 4.57 | 33.0% |
| 0QZ5.L | Cognizant Technology Solutions Corporation | $29.9B | |||
| CTSH | Cognizant Technology Solutions Corporation | $27.9B | 13.21 | 1.98 | 14.9% |
| FISV | Fiserv, Inc. | $26.4B | 9.64 | 1.00 | 10.8% |
Price
| Price | $15.90 |
| Market Cap | $39M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -177.40% |
| Return on Invested Capital | -108.78% |
| Return on Assets | -79.77% |
| Gross Margin | 52.86% |
| Operating Margin | -134.06% |
| Net Margin | -135.66% |
Related companies: AEMD · ALUR · ANL · AYTU · CODX · ERNA · GOVX
Explore sector: Technology · Information Technology Services
More sections of EKSO: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks